Market Capitalization Comparison for NovoNordisk and Eli Lilly Over the Last 5 Years

Pharma Giants' Market Cap Soars Over 5 Years

__timestamp	Eli Lilly and Company	Novo Nordisk A/S
Tuesday, January 1, 2019	122369084370	915808743862.0308
Wednesday, January 1, 2020	153244924560	992801077492.3201
Friday, January 1, 2021	250521319860.00003	1681508787391.9998
Saturday, January 1, 2022	329891098240	2129286754102.3198
Sunday, January 1, 2023	526678270123.72	3139248089387.3394

Unleashing insights

Market Capitalization: A Tale of Two Giants

In the past five years, the pharmaceutical titans Eli Lilly and Novo Nordisk have showcased remarkable growth in market capitalization. As of 2023, Novo Nordisk's market cap surged by an impressive 243% from its 2019 value, reaching a staggering 3.1 trillion. Meanwhile, Eli Lilly experienced a robust 330% increase, climbing to 527 billion. This growth reflects the companies' strategic innovations and expanding influence in the global healthcare sector. While Novo Nordisk leads with a market cap nearly six times that of Eli Lilly, both companies have demonstrated resilience and adaptability in a rapidly evolving market. Investors and industry watchers should keep a keen eye on these powerhouses as they continue to shape the future of pharmaceuticals.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

9 Dec 2024